(BO) vs 140 mg/dl (BF) Nuits avec ? 1 hypo, pp.14714-14721 ,
aucun risque détecté Au orange : modifications de l'insulinothérapie en cours car hypo ou hyperglycémie prédite ; Au rouge : intervention du patient nécessaire ,
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies, BMJ, vol.342, issue.apr13 5, p.1855, 2011. ,
DOI : 10.1136/bmj.d1855
Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp, New England Journal of Medicine, vol.368, issue.9, pp.824-833, 2013. ,
DOI : 10.1056/NEJMoa1206881
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia, Diabetes, vol.61, issue.9, pp.2230-2237, 2012. ,
DOI : 10.2337/db11-1445
Artificial Pancreas: Past, Present, Future, Diabetes, vol.60, issue.11, pp.2672-2682, 2011. ,
DOI : 10.2337/db11-0654
Closed-loop insulin delivery: from bench to clinical practice, Nature Reviews Endocrinology, vol.30, issue.7, pp.385-395, 2011. ,
DOI : 10.1038/nrendo.2011.32
Algorithms for a Closed-Loop Artificial Pancreas: The Case for Proportional-Integral-Derivative Control, Journal of Diabetes Science and Technology, vol.6, issue.2, pp.1621-1631, 2013. ,
DOI : 10.2337/db11-1445
Algorithms for a Closed-Loop Artificial Pancreas: The Case for Model Predictive Control, Journal of Diabetes Science and Technology, vol.375, issue.9716, pp.1632-1643, 2013. ,
DOI : 10.1089/dia.2012.0283
Challenges and recent progress in the development of a closed-loop artificial pancreas, Annual Reviews in Control, vol.36, issue.2, pp.255-266, 2012. ,
DOI : 10.1016/j.arcontrol.2012.09.007
Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery: Feasibility study testing a new model for the artificial pancreas, Diabetes Care, vol.33, issue.1, pp.121-127, 2010. ,
DOI : 10.2337/dc09-1080
URL : https://hal.archives-ouvertes.fr/hal-00482976
Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas, Diabetes Care, vol.31, issue.5, pp.934-939, 2008. ,
DOI : 10.2337/dc07-1967
Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes, Diabetes Care, vol.33, issue.10, pp.10-2152, 2010. ,
DOI : 10.2337/dc10-0692
Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy., Journal of Clinical Investigation, vol.74, issue.3, pp.985-991, 1984. ,
DOI : 10.1172/JCI111519
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes, Physiological Measurement, vol.25, issue.4, pp.905-920, 2004. ,
DOI : 10.1088/0967-3334/25/4/010
Assessing Performance of Closed-Loop Insulin Delivery Systems by Continuous Glucose Monitoring: Drawbacks and Way Forward, Diabetes Technology & Therapeutics, vol.15, issue.1, pp.4-12, 2013. ,
DOI : 10.1089/dia.2012.0185
Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes, Diabetes, vol.55, issue.12, pp.3344-3350, 2006. ,
DOI : 10.2337/db06-0419
The Effect of Insulin Feedback on Closed Loop Glucose Control, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.5, pp.1402-1408, 2011. ,
DOI : 10.1210/jc.2010-2578
Closed-Loop Insulin Therapy Improves Glycemic Control in Children Aged <7 Years: A randomized controlled trial, Diabetes Care, vol.36, issue.2, pp.222-227, 2013. ,
DOI : 10.2337/dc12-1079
Clinical Evaluation of a Personalized Artificial Pancreas, Diabetes Care, vol.36, issue.4, pp.801-809, 2013. ,
DOI : 10.2337/dc12-0948
Multivariable Adaptive Closed-Loop Control of an Artificial Pancreas Without Meal and Activity Announcement, Diabetes Technology & Therapeutics, vol.15, issue.5, pp.386-400, 2013. ,
DOI : 10.1089/dia.2012.0283
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: The Virginia Experience, Journal of Diabetes Science and Technology, vol.54, issue.10, pp.1031-1038, 2009. ,
DOI : 10.1177/193229680700100303
MD-Logic Artificial Pancreas System: A pilot study in adults with type 1 diabetes, Diabetes Care, vol.33, issue.5, pp.1072-1076, 2010. ,
DOI : 10.2337/dc09-1830
Feasibility of a Bihormonal Closed-Loop System to Control Postexercise and Postprandial Glucose Excursions, Journal of Diabetes Science and Technology, vol.88, issue.10, pp.1114-1122, 2012. ,
DOI : 10.1126/scitranslmed.3000619
Artificial Pancreas Using a Personalized Rule-Based Controller Achieves Overnight Normoglycemia in Patients with Type 1 Diabetes, Diabetes Technology & Therapeutics, vol.16, issue.3, pp.172-179, 2014. ,
DOI : 10.1089/dia.2013.0229
Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial, Diabetes Care, vol.36, issue.4, pp.838-844, 2013. ,
DOI : 10.2337/dc12-0816
Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas, Diabetes Care, vol.35, issue.11, pp.2148-2155, 2012. ,
DOI : 10.2337/dc12-0071
Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus, Diabetes & Metabolism, vol.40, issue.3, pp.211-214, 2014. ,
DOI : 10.1016/j.diabet.2013.12.001
Autonomous and Continuous Adaptation of a Bihormonal Bionic Pancreas in Adults and Adolescents With Type 1 Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.5, pp.1701-1711, 2014. ,
DOI : 10.1210/jc.2013-4151
Prandial Insulin Dosing Using Run-to-Run Control: Application of clinical data and medical expertise to define a suitable performance metric, Diabetes Care, vol.30, issue.5, pp.1131-1136, 2007. ,
DOI : 10.2337/dc06-2115
???in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Therapy: A Randomized Controlled Trial, Diabetes Technology & Therapeutics, vol.14, issue.11, pp.1043-1052, 2012. ,
DOI : 10.1089/dia.2012.0145
Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms, Diabetes Care, vol.37, issue.5, pp.1191-1197, 2014. ,
DOI : 10.2337/dc13-2108
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994938
The Content of Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications for Artificial Pancreas Device Systems, 2014. ,
Hypoglycemia: Incidence and Clinical Predictors in a Large Population-Based Sample of Children and Adolescents with IDDM, Diabetes Care, vol.20, issue.1, pp.22-25, 1997. ,
DOI : 10.2337/diacare.20.1.22
Dead-in-bed syndrome in young diabetic patients, Diabetes Care, vol.22, issue.2, pp.40-42, 1999. ,
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes, New England Journal of Medicine, vol.363, issue.4, pp.311-320, 2010. ,
DOI : 10.1056/NEJMoa1002853
A Controlled Study of the Effectiveness of an Adaptive Closed-Loop Algorithm to Minimize Corticosteroid-Induced Stress Hyperglycemia in Type 1 Diabetes, Journal of Diabetes Science and Technology, vol.12, issue.11, pp.1312-1326, 2011. ,
DOI : 10.1088/0967-3334/25/4/010
Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes, Diabetes Care, vol.34, issue.2, pp.406-411, 2011. ,
DOI : 10.2337/dc10-1796
Safety and Efficacy of 24-h Closed-Loop Insulin Delivery in Well-Controlled Pregnant Women With Type 1 Diabetes: A randomized crossover case series, Diabetes Care, vol.34, issue.12, pp.2527-2529, 2011. ,
DOI : 10.2337/dc11-1430
Feasibility of Closed-Loop Insulin Delivery in Type 2 Diabetes: A Randomized Controlled Study, Diabetes Care, vol.37, issue.5, pp.1198-1203, 2014. ,
DOI : 10.2337/dc13-1030
Perioperative glycemic control using an artificial endocrine pancreas in patients undergoing total pancreatectomy: tight glycemic control may be justified in order to avoid brittle diabetes, Biomed Mater Eng, vol.23, pp.109-116, 2013. ,
Tight perioperative glycemic control using an artificial endocrine pancreas, Surgery Today, vol.29, issue.1, pp.1-7, 2010. ,
DOI : 10.1007/s00595-009-4061-2
The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients*, Critical Care Medicine, vol.39, issue.3, pp.575-578, 2011. ,
DOI : 10.1097/CCM.0b013e318206b9ad
Feasibility of Outpatient Fully Integrated Closed-Loop Control: First studies of wearable artificial pancreas, Diabetes Care, vol.36, issue.7, pp.1851-1858, 2013. ,
DOI : 10.2337/dc12-1965
Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas, Diabetes Care, vol.37, issue.7, pp.1789-1796, 2014. ,
DOI : 10.2337/dc13-2076
Overnight Glucose Control With an Automated, Unified Safety System in Children and Adolescents With Type 1 Diabetes at Diabetes Camp, Diabetes Care, vol.37, issue.8, pp.2310-2316, 2014. ,
DOI : 10.2337/dc14-0147
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial, The Lancet, vol.375, issue.9716, pp.743-751, 2010. ,
DOI : 10.1016/S0140-6736(09)61998-X
Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management, Diabetes Care, vol.36, issue.12, pp.3882-3887, 2013. ,
DOI : 10.2337/dc12-1956
Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial, Diabetes Care, vol.37, issue.5, pp.1204-1211, 2014. ,
DOI : 10.2337/dc13-2644
First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas, Diabetes Care, vol.37, issue.5, pp.1212-1215, 2014. ,
DOI : 10.2337/dc13-1631
Day and Night Home Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes: Three-Center Randomized Crossover Study, Diabetes Care, vol.37, issue.7, pp.1931-1937, 2014. ,
DOI : 10.2337/dc13-2911
MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover Trial, Diabetes Care, vol.37, issue.11, pp.10-2337, 2014. ,
DOI : 10.2337/dc14-0835
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes, New England Journal of Medicine, vol.371, issue.4, pp.313-325, 2014. ,
DOI : 10.1056/NEJMoa1314474
The Use of an Automated, Portable Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes, Diabetes Care, vol.35, issue.11, pp.2182-2187, 2012. ,
DOI : 10.2337/dc12-0761
Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes, Diabetes Care, vol.36, issue.10, pp.2909-2914, 2013. ,
DOI : 10.2337/dc13-0010
Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes, Diabetes Care, vol.35, issue.9, pp.65-67, 2012. ,
DOI : 10.2337/dc12-0660
Closed-Loop System in the Management of Diabetes: Past, Present, and Future, Diabetes Technology & Therapeutics, vol.16, issue.8, pp.477-490, 2014. ,
DOI : 10.1089/dia.2014.0193
Insulin Patch Pumps: Their Development and Future in Closed-Loop Systems, Diabetes Technology & Therapeutics, vol.12, issue.S1, pp.51-58, 2010. ,
DOI : 10.1089/dia.2010.0016
Stable Liquid Glucagon Formulations for Rescue Treatment and Bi-Hormonal Closed-Loop Pancreas, Current Diabetes Reports, vol.281, issue.6, pp.705-710, 2012. ,
DOI : 10.1007/s11892-012-0320-5
Iatrogenic glucagonoma syndrome?], Ann Dermatol Venereol, vol.115, pp.717-719, 1988. ,
REPRODUCTION OF FEATURES OF THE GLUCAGONOMA SYNDROME WITH CONTINUOUS INTRAVENOUS GLUCAGON INFUSION AS THERAPY FOR TUMOR-INDUCED HYPOGLYCEMIA, Endocrine Practice, vol.9, issue.1, pp.22-25, 2003. ,
DOI : 10.4158/EP.9.1.22
Mishandling of the Therapeutic Peptide Glucagon Generates Cytotoxic Amyloidogenic Fibrils, Pharmaceutical Research, vol.21, issue.7, pp.1274-1283, 2004. ,
DOI : 10.1023/B:PHAM.0000033016.36825.2c
Undeniable Need for Ultrafast-Acting Insulin: The Pediatric Perspective, Journal of Diabetes Science and Technology, vol.31, issue.5, pp.797-801, 2012. ,
DOI : 10.1177/193229681200600409
Does the Fat-Protein Meal Increase Postprandial Glucose Level in Type 1 Diabetes Patients on Insulin Pump: The Conclusion of a Randomized Study, Diabetes Technology & Therapeutics, vol.14, issue.1, pp.16-22, 2012. ,
DOI : 10.1089/dia.2011.0083
Parental Attitudes Towards Overnight Closed-Loop Glucose Control in Children with Type 1 Diabetes, Diabetes Technology & Therapeutics, vol.12, issue.1, pp.35-39, 2010. ,
DOI : 10.1089/dia.2009.0084